Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

CYTOO Sponsors the Motility Subgroup at the Biophysical Society Meeting

Published: Monday, January 28, 2013
Last Updated: Monday, January 28, 2013
Bookmark and Share
CYTOO will attend the Biophysical Society (BPS) 57th Annual Meeting in Philadelphia, Pennsylvania, USA to present its innovative Cell Culture Platform, based on adhesive micropatterns.

After the recent launch of the CYTOOplates Motility, specifically designed to study cell migration for screening applications in both oncology and drug discovery, the company has the great pleasure to sponsor the Motility subgroup.

The Biophysical Society’s subgroups allow members to meet and interact within more focusedCYTOOplates-Motility.gif areas in smaller groups. Subgroups hold scientific symposia and business meetings each year on Saturday preceding the start of the Annual Meeting. The mission of the Motility Subgroup is to understand the basic mechanisms that underlie motility and contractility of biological systems.

CYTOO is delighted to have the opportunity to present the Motility products and their unique characteristics to the subgroup members. To celebrate the first anniversary of the World Cell Race1, CYTOO launched in December the CYTOOplates Motility, the microplate version of the CYTOOchips Motility, a perfect tool for studying cell migration, showing characteristics closer to those found in vivo2.

CYTOO’s Motility products feature adhesive tracks of 4 different widths from 2.5 to 20 μm allowing a wide range of applications including single vs collective cell migration, cell pairing, and in other application areas, such as directional neurite outgrowth assays.

Attendees are invited to visit BPS booth #650 to discover the Motility products, and to discuss their 2D+ application with Alexandra Fuchs, PhD, COO, and Yoran Margaron, PhD, Research Scientist.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Olivier Pasquier Joins CYTOO as Chief Commercial Officer
Olivier Pasquier first graduated from the French University Nice-Sophia Antipolis in molecular biology. He then completed his background with a marketing MBA from ESCP Europe.
Monday, March 18, 2013
Scientific News
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos